Revenue Performance - Revenue for Q3 2024 was 20.2million,consistentwithQ32023revenue[3]−Revenueforthefirstninemonthsof2024was58.7 million, compared to 57.8millioninthesameperiodof2023[12]−ForthethreemonthsendedSeptember30,2024,netsalesincreasedto20,179,000 compared to 20,069,000forthesameperiodin2023,representingagrowthof0.550.67 basic and 0.63diluted,comparedto0.03 EPS in Q3 2023[10] - Non-GAAP adjusted EPS increased to 0.75basicand0.71 diluted from 0.33inQ32023[10]−OperatingincomeforQ32024was2.6 million, compared to 594,000inQ32023[9]−Non−GAAPadjustedEBITDAforQ32024was3.1 million, up from 662,000inQ32023[11]−NetincomeforthethreemonthsendedSeptember30,2024,was2,357,000, compared to a net income of 90,000forthesameperiodin2023,reflectingasubstantialincreaseof2,5190.63 for the three months ended September 30, 2024, compared to 0.03forthesameperiodin2023,asignificantincreaseof2,0001.65 from 1.50,andnon−GAAPEPStargetincreasedto1.92 from 1.77[3]OrderandBacklogInformation−Orderbacklogreached27.0 million, up from 21.8millioninQ32023and26.9 million in Q2 2024[3] Asset and Liability Management - Total current assets decreased to 34,916,000asofSeptember30,2024,downfrom37,202,000 at the end of 2023, a decline of 8.66%[24] - Total liabilities decreased to 20,417,000asofSeptember30,2024,comparedto28,097,000 at the end of 2023, a reduction of 27.49%[25] - The accumulated deficit improved to (19,507,000)asofSeptember30,2024,from(24,209,000) at the end of 2023, reflecting a reduction of 19.67%[25] Shareholder Information - The weighted average common shares outstanding, basic, increased to 3,539,841 for the three months ended September 30, 2024, compared to 3,411,813 for the same period in 2023, an increase of 3.77%[26] Investment in Development - The company has capitalized product development costs of $751,000 as of September 30, 2024, indicating ongoing investment in new product development[24]